While we all love to hate the man with the most punchable face in America, Martin Shkreli, his despicable actions shed light on a situation all Americans will face at some time in our lives. The cost of prescription drugs is skyrocketing, and even with insurance picking up most of the tab, seniors are struggling to pay for life-saving new medicines. Unless something changes, prices will continue to go up.
In 2015, the FDA approved a slew of new drugs to treat everything from hepatitis C to MS. What those emotional commercials touting turnaround miracle drugs don't tell you is how much the miracle treatments cost...and it might be $50,000 and up per year. Even with Medicare, your out-of-pocket costs can run thousands of dollars. If you were prescribed rheumatoid arthritis drug Humira, for example, the total cost would be $42,059, and Medicare would pay all but $4,864 - a hefty price tag for a senior on a fixed income.
How Big is The Issue?
Americans spend more than any other country on drugs. Even the price of generic drugs spiked last year.
A state-by-state analysis of the money spent on drugs each year reveals astonishing amounts. As you might expect, states with more cattle than people such as Wyoming spend the least - $464,949,828 - while densely populated states like California spend the most - $35,260,741,888 in 2015.
Why are drug prices so high in the U.S.?
It's a complicated issue, but with U.S. drug sales exceeding $10 billion a year and company profits at about 30 percent, it's hard to avoid the word "profiteering." The U.S. is one of the only nations that does not regulate pharmaceutical prices.
Perfectly legal and utterly reprehensible tactics big pharma uses to keep prices high:
"Pay-for-delay" patent settlements, where the big pharma companies pay generic drug manufacturers to not make low-cost generic versions of their expensive drugs. It's a win-win for both companies. Generic drug companies get paid to do nothing; the original drug company continues to pocket outrageous profits. The only losers are the patients and their insurance companies...especially taxpayer-funded Medicare.
"Evergreening" - keeping their exclusivity alive by releasing a new drug with some tiny change, like time-release, or a different method of delivery (chewable, coated capsule, etc). The "new" version is usually a more of a marketing gimmick than an upgrade.
Pharmaceutical companies justify prices by citing the high cost of research and development. Typical arguments include the high value of new drugs to society, the search for cures that did not exist before.
It's an argument that makes perfect sense without context. The big picture shows pharmaceutical companies pocketing huge profits and spending far more on marketing and administration than on the noble pursuit of R&D.
The Consequences
The FDA reports that 20 to 30 percent of prescriptions are never filled.
In the Journal of the National Cancer Institute, Yousuf Zafar of the Duke Cancer Institute wrote, "Evidence suggests that a considerably large proportion of cancer patients are affected by treatment-related financial harm. As medical debt grows for some with cancer, the downstream effects can be catastrophic, with a recent study suggesting a link between extreme financial distress and worse mortality"
What Do Our Presidential Candidates Propose?
Hillary Clinton's plan:
- Stop direct-to-consumer drug company advertising subsidies, and reinvest funds in research.
- Require drug companies that benefit from taxpayers' support to invest in research, not marketing or profits.
- Cap monthly and annual out-of-pocket costs for prescription drugs to save patients with chronic or serious health conditions hundreds or thousands of dollars.
- Increase competition for prescription drugs, including specialty drugs, to drive down prices and give consumers more choices.
- Clear out the FDA generic backlog
Increase competition for specialty drugs including new "biologic" drugs - which are often the most expensive new treatments
Prohibit "pay for delay" arrangements that keep generic competition off the market.Allow Americans to import drugs from abroad - with careful protections for safety and quality.Ensure American consumers are getting value for their drugs.Demand higher rebates for prescription drugs in Medicare. Allow Medicare to negotiate drug and biologic prices.Donald Trump's plan: Allow Americans to buy drugs from overseas.
One thing is certain. With a rapidly aging Baby Boomer generation and chronic conditions such as cancer, diabetes, and heart disease on the rise, we need viable solutions - and fast.
Our 2024 Coverage Needs You
It's Another Trump-Biden Showdown — And We Need Your Help
The Future Of Democracy Is At Stake
Our 2024 Coverage Needs You
Your Loyalty Means The World To Us
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
The 2024 election is heating up, and women's rights, health care, voting rights, and the very future of democracy are all at stake. Donald Trump will face Joe Biden in the most consequential vote of our time. And HuffPost will be there, covering every twist and turn. America's future hangs in the balance. Would you consider contributing to support our journalism and keep it free for all during this critical season?
HuffPost believes news should be accessible to everyone, regardless of their ability to pay for it. We rely on readers like you to help fund our work. Any contribution you can make — even as little as $2 — goes directly toward supporting the impactful journalism that we will continue to produce this year. Thank you for being part of our story.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
It's official: Donald Trump will face Joe Biden this fall in the presidential election. As we face the most consequential presidential election of our time, HuffPost is committed to bringing you up-to-date, accurate news about the 2024 race. While other outlets have retreated behind paywalls, you can trust our news will stay free.
But we can't do it without your help. Reader funding is one of the key ways we support our newsroom. Would you consider making a donation to help fund our news during this critical time? Your contributions are vital to supporting a free press.
Contribute as little as $2 to keep our journalism free and accessible to all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
As Americans head to the polls in 2024, the very future of our country is at stake. At HuffPost, we believe that a free press is critical to creating well-informed voters. That's why our journalism is free for everyone, even though other newsrooms retreat behind expensive paywalls.
Our journalists will continue to cover the twists and turns during this historic presidential election. With your help, we'll bring you hard-hitting investigations, well-researched analysis and timely takes you can't find elsewhere. Reporting in this current political climate is a responsibility we do not take lightly, and we thank you for your support.
Contribute as little as $2 to keep our news free for all.
Can't afford to donate? Support HuffPost by creating a free account and log in while you read.
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. Would you consider becoming a regular HuffPost contributor?
Dear HuffPost Reader
Thank you for your past contribution to HuffPost. We are sincerely grateful for readers like you who help us ensure that we can keep our journalism free for everyone.
The stakes are high this year, and our 2024 coverage could use continued support. If circumstances have changed since you last contributed, we hope you'll consider contributing to HuffPost once more.
Support HuffPostAlready contributed? Log in to hide these messages.